KPV (Lys-Pro-Val) Product Brief

1. Compound Overview

KPV (Lysine–Proline–Valine) is a naturally occurring tripeptide derived from the C‑terminal end of alpha‑melanocyte‑stimulating hormone (α‑MSH).
It has been studied for its potential role in anti‑inflammatory signaling and immune response modulation.

KPV has attracted research interest in dermatological, gastrointestinal, and immune system studies due to its potential influence on inflammatory pathways and cellular signaling processes.

2. Mechanism of Interest

KPV is studied for several biological mechanisms:

• Potential modulation of inflammatory cytokine signaling
  • Interaction with immune regulatory pathways
  • Possible influence on NF‑κB inflammatory signaling pathways
  • Investigated for skin and gastrointestinal inflammatory models
  • Potential cellular protective and tissue‑repair related signaling

3. Research Areas Being Explored

• Inflammation and immune response research
  • Dermatological and skin barrier studies
  • Gastrointestinal inflammatory pathway research
  • Wound healing and tissue repair models
  • Cellular signaling and immune modulation studies

4. Safety and Regulatory Notes

KPV is not approved by the FDA for medical treatment and is commonly distributed as a research compound.

This document is intended for informational and research product description purposes only.